latest news

REGiMMUNE and Kiji Therapeutics Announce Intention to Merge
Kiji – iPSC/MSC engineered cell therapy for inflammatory disease
Our CEO, Miguel Forte, spoke about Kiji Therapeutics’ projects at the Alliance for Regenerative Medicine Studios.
Miguel Forte, CEO of Kiji Therapeutics, presents the company at the Cell & Gene Meeting on the Mesa 2023

why kiji ?

Our name, « Kiji, » meaning « pheasant » in Japanese, is inspired by the Pheasant Island, which alternates sovereignty between Spain and France every six months. Additionally, according to a Japanese legend, a pheasant named Hō-ō was living in the forest when a fire broke out, threatening to destroy the trees and animals. Hō-ō sacrifices itself by flying into the fire to re-born as a majestic phoenix, bringing healing and renewal to the burned forest and its inhabitants. Like Hō-ō, Kiji is committed to the new era, offering hope and renewal to patients with inflammatory conditions.